scholarly journals New Advances in the Fertility Awareness Method and the Treatment of Stress Urinary Incontinence (SUI)

Author(s):  
Shihata Alfred ◽  
Brody Steven A ◽  
Linderoth Birgit ◽  
Julia Barrett Mitchell
2021 ◽  
pp. 1-6
Author(s):  
Shihata Alfred ◽  
◽  
Brody Steven A ◽  

This article addresses three unmet women’s reproductive health needs, and how the FemCap can fulfill these needs. The FemCap is an FDA-approved, non-hormonal contraceptive device that can accommodate some deficient areas of women’s health: 1. A scarcity of hormone-free contraceptive methods. 2. Enhancement of fertility awareness method that is infrequently used but is the safest method. 3. Help Millions of women who suffer silently from stress urinary incontinence. The FemCap blocks sperm from entering the cervix. It is time-tested to be safe and effective for contraception. Using the FemCap directly at the cervix, it can collect the fertile cervical mucus without mixing it with any other vaginal fluid. Current pessaries used to treat stress urinary incontinence (SUI) have significant drawbacks, including displacement, erosion, ulceration, of the vagina and urethral blockage. The rim of the FemCap performs the same function as the ring pessary by supporting the bladder neck. The outward flared brim restores the urethra and vaginal anatomy. At the same time, the bowl of the FemCap keep the cervix from prolapsing further. The FemCap is a long-established barrier method of contraception, and pilot studies results show it can improve fertility awareness methods and manage Stress Urinary Incontinence. It would be ideal and cost-effective to have a single reusable device with several functions for contraceptives, increasing the acceptability and effectiveness of fertility awareness methods, and stress urinary incontinence control. The FemCap would be an ideal alternative to the condom.


2021 ◽  
Vol 5 (2) ◽  

Introduction: The FemCap is an FDA, and CE mark approved barrier contraceptive device. To our surprise, it was found to apply to several basic unmet reproductive health needs for women. a) The FemCap is time tested hormone-free contraceptive device, b) It offers an alternative delivery system to the traditional vaginal applicator, c) It provides a safe and effective non-surgical treatment for stress urinary incontinence (SUI), d) It enhances the fertility awareness methods. Methodology: We conducted several pilot studies to explore the potential of the FemCap. We compared the retention and distribution of stained vaginal gel if inserted with the FemCap versus the same amount of gel when inserted by the vaginal applicator. We compared the safety and effectiveness of the FemCap with a vaginal pessary that treats stress urinary incontinence. We collected the fertile cervical mucous (Spinnbarkeit) with the FemCap to determine the time of ovulation to enhance the fertility awareness method. Results: The FemCap is a well-established, safe, and effective non-hormonal contraceptive. The retention and distribution of stained vaginal gel inserted with the FemCap is more efficient than the vaginal applicator. The FemCap’s unique storage groove for microbicides can potentially be utilized to treat sexually transmitted infections (STIs) topically. FemCap is also found to be substantially equivalent to the incontinence pessary in controlling stress urinary incontinence (SUI). The FemCap did also help to collect fertile cervical mucous (Spinnbarkeit) when using fertility awareness methods. Conclusion: The multipurpose FemCap would be an ideal tool for nurse practitioners, midwives, and physicians to provide women with safe and effective, hormone-free contraception. It also provides an efficient delivery system for spermicide/microbicides. It is much safer for non-surgical management of stress urinary incontinence. It is useful for the enhancement of fertility awareness methods. It is non-invasive and can be inserted and removed by the woman without professional help.


2007 ◽  
Vol 177 (4S) ◽  
pp. 453-454
Author(s):  
Rachelle L. Prantif ◽  
William C. de Groat ◽  
Donna J. Haworth ◽  
Ronald J. Jankowski ◽  
Michael B. Chancellor ◽  
...  

2006 ◽  
Vol 175 (4S) ◽  
pp. 110-110 ◽  
Author(s):  
Robert D. Moore ◽  
John Miklos ◽  
L. Dean Knoll ◽  
Mary Dupont ◽  
Mickey Karram ◽  
...  

2006 ◽  
Vol 175 (4S) ◽  
pp. 380-380
Author(s):  
Asnat Groutz ◽  
Ronen Gold ◽  
David Pauzner ◽  
Joseph Lessing ◽  
David Gordon

2004 ◽  
Vol 171 (4S) ◽  
pp. 132-132 ◽  
Author(s):  
Peter J. Gilling ◽  
Wilhelm A. Huebner ◽  
Flavio T. Rocha ◽  
Marcus V. Sadi ◽  
Oliver M. Schlarp

2004 ◽  
Vol 171 (4S) ◽  
pp. 249-249
Author(s):  
Paulo Palma ◽  
Cassio Riccetto ◽  
Marcelo Thiel ◽  
Miriam Dambros ◽  
Rogerio Fraga ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document